Morinidazole solution
Based on 1 publication(s) in Google Scholar
Morinidazole solution is a solution whose main component is Morinidazole (HY-15781). Morinidazole is an orally effective 5-nitroimidazole antibacterial agent that exerts its activity through nitroreduction within pathogens. Morinidazole is metabolized in vivo through N+-glucuronidation and sulfation. Morinidazole can be used for research on bacterial infections, including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 92478-27-8
- Formule: C11H18N4O4
- Masse moléculaire:270.29
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Morinidazole solution
More
Activité biologique
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:SD rats (male; 5/6 nephrectomized (5/6 Nx))[2]
-
Dosage:50 mg/kg
-
Administration:tail vein injection; single administration; continuous blood sampling and monitoring up to 12 h
-
Result:Led to a significant increase in the plasma exposure (AUC) of conjugated metabolites (M7, M8-1, M8-2).
Chemical Information
-
CAS No. 92478-27-8
-
Masse moléculaire 270.29
-
Formule C11H18N4O4
-
SMILES
OC(CN1CCOCC1)CN2C([N+]([O-])=O)=CN=C2C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Pureté et documentation
Références
[1]. Zhong K, et al. Effects of renal impairment on the pharmacokinetics of morinidazole: uptake transporter-mediated renal clearance of the conjugated metabolites. Antimicrobial agents and chemotherapy. 2014 Jul;58(7):4153-61. [Content Brief]
[2]. Kong F, et al. Increased Plasma Exposures of Conjugated Metabolites of Morinidazole in Renal Failure Patients: A Critical Role of Uremic Toxins. Drug metabolism and disposition: the biological fate of chemicals. 2017 Jun;45(6):593-603. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)